The Decision Regarding the Pricing Regulation for Human Medicinal Products in Turkey has been amended. The Decision Amending the Decision on Pricing of Human Medicinal Products ("Amendment Decision") was published in Official Gazette number 30686 on 14 February 2019, entering into effect on the same date.
According to the Decision on Pricing of Human Medicinal Products, in order to determine the Turkish Lira equivalent of 1 Euro for the pricing of the human medicinal products, the adjustment coefficient which is 70% of annual average Euro value calculated based on the previous year's indicative Euro exchange rates of Central Bank of The Turkish Republic is taken into account.
The Turkish Lira equivalent of 1 Euro used in the pricing of human medicinal products is calculated according to the method declared by the Price Evaluation Commission and announced within the first 45 days of each year.
The Amendment Decision which is published on 14 February 2019 changes the adjustment coefficient rate. Pursuant to the change, the adjustment coefficient rate has decreased from 70% to 60%.
Please see this link for the full text of the Amendment Decision (only available in Turkish).
"Information first published in the MA | Gazette, a fortnightly legal update newsletter produced by Moroğlu Arseven."
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.